Estimating the health care savings from trans fat-free canola in Canada

Malla, Stavroula; Hobbs, Jill E.; Perger, Orsolya

doi:10.1080/16507540500534911

Cited by 11 publications

(9 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Here, we focus specifically on the use of phytosterols and relations with perceptions of impacts on levels of blood cholesterol and, in turn, the personal risk of CVD. More generally, the results address the paucity of studies on consumer acceptance of functional foods and nutraceuticals in Canada (with the notable exceptions of West et al, 2002;Labrecque et al, 2006;Malla et al, 2005;Henson et al, 2008), recognizing that attitudes towards such products tend to be culture specific (Bech-Larsen et al, 2001;Labrecque et al, 2006).…”

Section: Introductionmentioning

confidence: 73%

“…Significant potential public health and economic benefits from consumption of food products and/or non‐prescription pills containing phytosterols (see, for example, Malla et al. , 2005; Gerber et al.…”

Section: Introductionmentioning

confidence: 99%

“…Significant potential public health and economic benefits from consumption of food products and/or non-prescription pills containing phytosterols (see, for example, Malla et al, 2005;Gerber et al, 2006) have been estimated, although the realization of these benefits is dependent on the propensity of consumers to make commensurate changes in their diets. Indeed, the importance of understanding consumer perceptions of functional foods and nutraceuticals, alongside other food technologies, has been recognized (see, for example, Wrick, 1993;Childs and Poryzees, 1997;Gilbert, 2000;Frewer et al, 2003;Verbeke, 2005;Niva, 2007;Blandon et al, 2008;Herath et al, 2008).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Understanding consumer receptivity towards foods and non‐prescription pills containing phytosterols as a means to offset the risk of cardiovascular disease: an application of protection motivation theory

Henson

Cranfield

Herath

2010

Int J Consumer Studies

View full text Add to dashboard Cite

Consumer purchase intention with respect to foods and non‐prescription pills containing phytosterols was investigated through a mall intercept survey (n = 446) in Ontario, Canada. The study took as its starting point the Protection Motivation Theory (PMT), a social cognition model rooted in research on fear appeal in determining health‐protective behaviour. Structural equation modelling was used to explore whether an adaptation of PMT explains intention to purchase products containing phytosterols as a means to reduce the risk of cardiovascular disease (CVD). The standard form of PMT was adapted to take account of consumer perceptions of the risk of elevated blood cholesterol, reflecting the fact that phytosterols do not directly reduce the risk of CVD but rather help in the management of a single risk factor. Overall, coping appraisal had a positive and significant association with purchase intention, while threat appraisal had no significant effect. Incorporation of cholesterol as a risk factor for CVD significantly improved the measurement strength of the threat appraisal construct. However, the overall predictive power of the model did not change appreciably. The results suggest that the promotion of adaptive behaviours, such as consumption of functional foods and nutraceuticals, needs to focus on perception of response and self‐efficacy rather than individual perceptions of risk.

show abstract

Section: Introductionmentioning

confidence: 73%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Understanding consumer receptivity towards foods and non‐prescription pills containing phytosterols as a means to offset the risk of cardiovascular disease: an application of protection motivation theory

Henson

Cranfield

Herath

2010

Int J Consumer Studies

View full text Add to dashboard Cite

show abstract

“…Indeed, a growing proportion of health-conscious consumers in many industrialized countries regularly use such products (Kotailainen et al, 2006). Not surprisingly, functional foods and nutraceuticals have been recognized as a significant business opportunity for the agri-food sector and, at the same time, a potentially effective means to promote health and well being in the population and reduce health-related costs (Malla et al, 2005).…”

Section: Introductionmentioning

confidence: 99%

Understanding the financing of innovation and commercialization: the case of the Canadian functional food and nutraceutical sector

Herath¹,

Cranfield²,

Henson³

2010

Applied Economics

View full text Add to dashboard Cite

We develop and implement two models to show what factors affect a firm's decision to seek external financing and the level of financing obtained in the Canadian functional food and nutraceutical sector. Data from a national survey of functional foods and nutraceutical firms in Canada, conducted by Statistics Canada in 2003, is used for this analysis. Firm size, being privately held and engaging in contractual arrangements have negative impacts on the likelihood of a firm seeking external funding, while firms which are intensively involved in the functional food and nutraceutical sector, with greater prospects for business expansion and/or involved in partnerships are more likely to seek external financing. Larger firms and those involved in functional food and nutraceutical research and development receive a greater amount of capital when they decide to raise capital. However, firms focused on functional foods and nutraceuticals, as opposed to more diversified firms, and those involved in product development and concept scale-up, receive less capital. Our findings highlight the importance of public support in addressing the capital requirements of functional food and nutraceutical firms and underscore the considerable burden borne by smaller firms in this respect.

show abstract

“…This spurred a growth of vegetable oil production and consumption. Mounting evidence that vegetable oil's high saturated fatty acids also increased the risk of coronary heart disease prompted food manufacturers and food service groups to begin evaluating alternative fats and oils (e.g., Malla, Hobbs, & Perger, 2005). This spurred a move away from tropical oils toward the use of soybean, canola, and other vegetable oils.…”

Section: Introductionmentioning

confidence: 99%